KalVista Pharmaceuticals (KALV) announced that Brian Piekos has joined the company as CFO. Piekos has more than 25 years of financial and strategic planning experience in the biopharmaceutical industry. He joins KalVista from Elicio Therapeutics (ELTX) where he served as CFO and was responsible for launching Elicio as a public company.
Education
About Us
Working with TipRanks
Follow Us
1